| Filed On | Filing |
|---|---|
| 18 Mar 2024 |
Form 4: Wheadon David E., Director
Returned 990 shares to the issuer ($327K) · Disposed of 40,404 Option (right to buy) (Disposition to Issuer) ($8.91M) |
| 18 Mar 2024 |
Form 4: Torres Denice, Director
Returned 990 shares to the issuer ($327K) · Disposed of 40,404 Option (right to buy) (Disposition to Issuer) ($8.67M) |
| 18 Mar 2024 |
Form 4: Pande Atul, Director
Returned 990 shares to the issuer ($327K) · Disposed of 27,904 Option (right to buy) (Disposition to Issuer) ($5.93M) |
| 18 Mar 2024 |
Form 4: Olson Laurie J, Director
Returned 990 shares to the issuer ($327K) · Disposed of 28,404 Option (right to buy) (Disposition to Issuer) ($6.21M) |
| 18 Mar 2024 |
Form 4: Jonas Jeffrey M, Director
Returned 990 shares to the issuer ($327K) · Disposed of 35,297 Option (right to buy) (Disposition to Issuer) ($9.45M) · Disposed of 28,750 Option (right to buy (Disposition to Issuer) ($8.01M) |
| 18 Mar 2024 |
Form 4: Healy James, Director
Returned 1,414,639 shares to the issuer ($467M) · Disposed of 27,904 Option (right to buy) (Disposition to Issuer) ($5.93M) |
| 18 Mar 2024 |
Form 4: Paul Steven M, Director
Returned 150,963 shares to the issuer ($49.8M) · Disposed of 2,600,667 Option (right to buy) (Disposition to Issuer) ($780M) |
| 18 Mar 2024 |
Form 4: Miller Andrew Craig, President of R&D
Returned 23,389 shares to the issuer ($7.72M) · Disposed of 15,855 Restricted Stock Units (Disposition to Issuer) ($5.23M) · Disposed of 526,637 Option (right to buy) (Disposition to Issuer) ($143M) |
| 18 Mar 2024 |
Form 4: Coughlin Christopher J, Director
Returned 990 shares to the issuer ($327K) · Disposed of 41,380 Option (right to buy) (Disposition to Issuer) ($9.25M) |
| 18 Mar 2024 |
Form 4: Brown Jason Parker, Chief Financial Officer
Returned 21,167 shares to the issuer ($6.99M) · Disposed of 10,306 Restricted Stock Units (Disposition to Issuer) ($3.4M) · Disposed of 34,951 Option (right to buy) (Disposition to Issuer) ($6.53M) |
| 18 Mar 2024 |
Form 4: Meury William, Director
Returned 29,379 shares to the issuer ($9.7M) · Disposed of 38,688 Restricted Stock Units (Disposition to Issuer) ($12.8M) · Disposed of 63,065 Option (right to buy) (Disposition to Issuer) ($8.63M) |
| 18 Mar 2024 |
Form 4: Kane William P Jr, Chief Commercial Officer
Returned 13,828 shares to the issuer ($4.56M) · Disposed of 10,306 Restricted Stock Units (Disposition to Issuer) ($3.4M) · Disposed of 29,937 Option (right to buy) (Disposition to Issuer) ($4.13M) |
| 18 Mar 2024 |
Form 4: Brannan Stephen K., Chief Medical Officer
Returned 42,604 shares to the issuer ($14.1M) · Disposed of 10,306 Restricted Stock Units (Disposition to Issuer) ($3.4M) · Disposed of 129,039 Option (right to buy) (Disposition to Issuer) ($28.3M) |
| 11 Mar 2024 |
Form 4: Brannan Stephen K., Chief Medical Officer
Received 7,500 shares by exercise or conversion ($637K) · Sold 5,000 shares ($1.59M) |
| 04 Mar 2024 |
Form 4: Paul Steven M, Director
Acquired 47,378 shares (Other Transaction) ($14.9M) · Gave 60,608 shares as a gift · Acquired 60,608 shares (Gift) · 2 more |
| 26 Feb 2024 |
Form 4: Paul Steven M, Director
Received 31,518 shares by exercise or conversion ($600K) |
| 15 Feb 2024 |
Form 4: Kane William P Jr, Chief Commercial Officer
Granted 10,306 Restricted Stock Units |
| 15 Feb 2024 |
Form 4: Brannan Stephen K., Chief Medical Officer
Granted 10,306 Restricted Stock Units |
| 15 Feb 2024 |
Form 4: Brown Jason Parker, Chief Financial Officer
Gave up 278 shares to cover exercise price or tax ($88.4K) · Granted 10,306 Restricted Stock Units |
| 15 Feb 2024 |
Form 4: Miller Andrew Craig, President of R&D
Granted 15,855 Restricted Stock Units |
Loading...
